AH Lisanti Capital Growth »

Cytokinetics shares owned by AH Lisanti Capital Growth

Quarter-by-quarter ownership of Cytokinetics (CYTK) shares owned by AH Lisanti Capital Growth from 13F filings

Historical chart of AH Lisanti Capital Growth investment in Cytokinetics

Tip: Access up to 7 years of quarterly data

All positions including Cytokinetics held by AH Lisanti Capital Growth consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytokinetics by AH Lisanti Capital Growth

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.2M 51k 83.49
2022-09-30 $8.2M 170k 48.45
2022-06-30 $13M 333k 39.29
2022-03-31 $9.7M 265k 36.81
2021-12-31 $10M 219k 45.58

More positions owned by AH Lisanti Capital Growth

Modine Manufacturing (MOD)
Nutanix Cl A (NTNX)
Transmedics Group (TMDX)
Topbuild (BLD)
Pinnacle Financial Partners (PNFP)
Abercrombie & Fitch Cl A (ANF)
Applied Industrial Technologies (AIT)
Webster Financial Corporation (WBS)
Elf Beauty (ELF)
Q2 Holdings (QTWO)
Varonis Sys (VRNS)
Freshworks Class A Com (FRSH)
FormFactor (FORM)
Axonics Modulation Technolog (AXNX)
Viking Therapeutics (VKTX)

View all positions for AH Lisanti Capital Growth

Top funds holding Cytokinetics

Vanguard Group
Wellington Management Company
Caption Management
T. Rowe Price Associates
Henderson Group
Boxer Capital
Citadel Advisors
Partner Fund Management
Logos Global Management
Lord, Abbett & Co
Millennium Management
Artal Group
Barclays
Gts Securities
Goldman Sachs Group

View all funds holding Cytokinetics